Articles & Video
eBook: Human Antibody Repertoires
Discover key research strategies and technologies applied to human antibody repertoires in the path to developing therapeutics and vaccines.
REPORT: Antibody Engineering & Therapeutics State of the Industry 2021
This report of the antibody engineering and therapeutics sector reveals where activities have shifted in the last year, and which struggles remain.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
Novel Non-cancer Targets for Therapeutic Antibodies
We look at the latest work on developing non-cancer targets for therapeutic antibodies discussed by industry leaders at Antibody Engineering & Therapeutics.
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
Novel Antibody Therapeutic Modalities - Antibody Therapeutics eBook Series
We take an in-depth look at the novel antibody therapeutic modalities being developed and how they are tackling new non-cancer targets in this Antibody Therapeutics eBook.
Report: Partnering And Deal-Making in Pharma through the Pandemic
This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
42% of pharma industry believe cell and gene therapies to be most promising therapeutics
According to a recent study, 42% of pharma industry professionals predict cell and gene therapies are the therapeutic area that will see the fastest growth in the next 10 years.
80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months
How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.
REPORT: Antibody Therapeutic Modalities 2020
Global research study into the development, targets, challenges and technologies of different antibody therapeutic modalities.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
COVID-19 antibody therapeutic development - WHITEPAPER
This paper evaluates the antibody therapies for COVID-19 currently in clinical trials and preclinical development.
Antibody Engineering and Therapeutics Survey: Tell us your views
Take part in our huge antibody therapeutic modalities survey to be in with a chance of winning a free conference pass.
Novel technologies and approaches for optimizing antibody discovery - WHITEPAPER
This whitepaper examines some of the latest advancements in methods and technologies innovating the discovery of antibodies.
REPORT: Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics
Download the data report exploring Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics.
Designing novel protein therapeutics and identifying appropriate targets - WHITEPAPER
This whitepaper explores designing novel protein therapeutics and identifying appropriate targets - download it here.
42% of N American antibody therapeutic companies manufacture externally
We recently conducted a survey of antibody therapeutics professionals, revealing an overview of the state of the industry in 2019. Here we take a deep dive into the results around antibody manufacturing and drug delivery.
If you could ask your antibody therapeutics regulatory authority one question, what would it be?
Our recent survey revealed what antibody therapeutics professionals really think of the regulatory agencies governing the industry.